# Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities

> **NCT04667416** · PHASE2 · UNKNOWN · sponsor: **Amnio Technology, LLC** · enrollment: 82 (actual)

## Conditions studied

- Chronic Ulcer of Lower Extremity

## Interventions

- **BIOLOGICAL:** PalinGen Flow Amniotic Tissue Allograft

## Key facts

- **NCT ID:** NCT04667416
- **Lead sponsor:** Amnio Technology, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-19
- **Primary completion:** 2024-03
- **Final completion:** 2025-01-31
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2024-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04667416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04667416, "Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04667416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*